My Crossword Maker Logo
Powered by BrightSprout
Save Status:
or to save your progress. The page will not refresh.
Controls:
SPACEBAR SWITCHES TYPING DIRECTION
Answer Key:
Edit a Copy:
Make Your Own:
Crucigrama Sopa de Letras Hoja de Trabajo
Calificar este Puzzle:
Log in or sign up to rate this puzzle.

TBCR2021 FUN PUZZLE

Horizontales
A __ VALIDATION STRATIFIES PATIENTS THAT DIFFER IN OUTCOME
MEASUREMENT OR VARIABLE ASSOCIATED WITH CLINICAL OUTCOME
ASSOCIATED WITH RESPONSE TO THERAPY
STARTING MATERIAL FOR THE MAMMAPRINT ASSAY
STARTING MATERIAL FOR ONCOTYPE DX ASSAY
THE STUDY OF THE GENOME IN DRUG RESPONSE
FACTORS NEEDED FOR SELECTING PATIENTS AT MOST RISK OF RECURRENCE
MULTIGENE ASSAY WITH BOTH PROGNOSTIC AND PREDICTIVE VALUE
TWO EXAMPLES ARE SPLIT-SAMPLE AND LEAVE-1-OUT CROSS VALIDATION
VALUE IN PATIENT CARE
MULTIGENE ASSAY THAT WAS CRITICIZED FOR INCLUDING SAME PATIENTS IN BOTH DISCOVERY AND VALIDATION COHORTS
Verticales
__ DRIVES TREATMENT
CLINICAL OUTCOME IS ___ OF THERAPY WHEN CONSIDERING PROGNOSTIC VALUE
CHARACTERISTIC OF PREDICTIVE FACTORS TO THERAPY
VALUE BASED ON NORMALIZED EXPRESSION OF 21 GENES USED TO GUIDE TREATMENT
FACTORS USED FOR PATIENT MANAGEMENT
MULTIGENE ASSAY THAT COMPARED GENE EXPRESSION PROFILING TO HISTOLOGIC AND CLINICAL CRITERIA
TO AVOID UNDER OR OVER-TREATMENT NEED THIS TYPE OF FACTOR
TECHNICAL VALIDATION
A PROGNOSTIC FACTOR COMPRISING THE TNM SYSTEM